CoinShares Announces Q2 2025 Results

SAINT HELIER, Jersey, Aug. 29, 2025 /PRNewswire/ — CoinShares International Limited (“CoinShares” or “the Group”) (Nasdaq Stockholm: CS; USOTCQX: CNSRF), the leading European asset manager specialising in digital assets, has today published its results for the quarter ending 30th June 2025. Q2 2025 Financial Highlights  Asset Management fees of $30.0 million (Q2 2024: $28.3 million) Capital […]

Purepeak: Korean Anti-Aging Brand Chosen by European Pharmacies

Now available at Paris pharmacies and Europe’s largest online pharmacy platform– Building global trust through Clean Beauty and Sustainable Skincare SEOUL, South Korea, PARIS and MILAN, Aug. 29, 2025 /PRNewswire/ — Global trip-leisure beauty brand Purepeak has officially entered pharmacies in Paris, France, as well as Europe’s largest online pharmacy platform, Redcare Pharmacy. As pharmacies across […]

Antaisolar Releases 2024 ESG Report and Launches EcoRaise Global Ecological Co-construction Initiative

XIAMEN, China, Aug. 29, 2025 /PRNewswire/ — Amid global sustainable development momentum, Antaisolar, a renewable energy leader, officially held its “RAISE•2025” event, releasing its latest ESG report and unveiling the EcoRaise Global Ecological Co-construction Initiative. These efforts underscore Antaisolar’s dedication to integrating environmental, social, and governance principles into its core strategy and operations. During the event, Antaisolar […]

UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

26 scientific abstracts, including two oral presentations, demonstrate UCB’s ongoing commitment to advancing research for people living with epilepsies Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning in children and adults with Dravet syndrome or Lennox-Gastaut syndrome[2] Data provide insights on developmental and epileptic encephalopathies (DEEs), including a qualitative study addressing […]

UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

26 scientific abstracts, including two oral presentations, demonstrate UCB’s ongoing commitment to advancing research for people living with epilepsies Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning in children and adults with Dravet syndrome or Lennox-Gastaut syndrome[2] Data provide insights on developmental and epileptic encephalopathies (DEEs), including a qualitative study addressing […]

Blackview Unveils Its Next-Level Rugged Product Lineup at IFA 2025

SHENZHEN, China, Aug. 29, 2025 /PRNewswire/ — Blackview, a global leader in rugged mobile technology, is set to unveil its next-generation lineup of rugged smartphones, tablets, laptops, mini PCs, and smart accessories at IFA 2025 in Berlin, taking place from September 5 to 9—highlighting breakthroughs in AI integration, satellite communication, and built-in projection technology. Continue […]

Traitement clinique de la drépanocytose par édition de base de haute précision — le CS-101 de CorrectSequence Therapeutics obtient des résultats prometteurs chez la première patiente

SHANGHAI, 29 août 2025 /PRNewswire/ — CorrectSequence Therapeutics Co., Ltd. (Correctseq), une société de biotechnologie au stade clinique, pionnière de la transformer Base Editing (tBE) pour le traitement de maladies graves, a récemment annoncé la réussite du traitement de la première patiente atteinte de drépanocytose grâce à sa thérapie par édition de base de haute précision, le […]